Username Password
S&P 500: 1,351.68 Change: +0.14%

CELLDEX THERAPEUTICS INC (CLDX)

Overview
Price 5.20
Price Change Today 0.00 (0.00%)
P&P rating Rating: 4
Zacks Rank 3 - HOLD
Open Price $0.00
Previous Close $5.20
Daily Range $0.00 - $0.00
52-Week Range $2.05 - $5.66
Volume 0
chart
CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
Other Resources for CLDX
zacks.com
Commentary
Zacks Blog: Zacks #5 Rank Additions for Thursday
August 4, 2011
Zacks Blog: Company News for May 19, 2011
May 19, 2011
Zacks Blog: Zacks #5 Rank Additions for Wednesday
May 4, 2011
CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
 
Brokerage Analyst Recommendations
6 Brokerage Firms Covering CLDX
 
  
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 1.17
 
CLDX Ratings:BUY  SELL  HOLD
CLDX Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

5 Buy
0 Sell
 
Top Buy Analysis
BUY: CLDX Rating: 4
Company: CELLDEX THERAPEUTICS INC NEW
Points: 13.13
Start Price: $4.49
Start Date: 01/28/2012 4:56 PM
mkittels
mkittels
P&P Score: 54.86
Recs:
The company's stem cell work has promise. And the stock is up over 60% in a month.

Comments: 0 | Comment


Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
zantriocom
0.00 12/14/09 Zantrio.com Free Daily Stock Picks 12-14-09 0
Zacks_Analysts
0.00 12/20/10 ImmunoCellular Therapeutics (IMUC): At the Forefront of Brain Tumor Treatment - Analyst Blog 0
Zacks_Analysts
0.00 11/24/10 Good News for Celldex Therapeutics - Analyst Blog 0
Zacks_Analysts
0.00 09/07/10 Pfizer Terminates Deal - Analyst Blog 0
Commentary
BUY: CELLDEX THERAPEUTICS INC NEW (CLDX) Rating: 4
Start Price: $4.49
Points: +13.13
Created: 01/28/2012
The company's stem cell work has promise. And the stock is up over 60% in a month.

Comments: 0 | Comment

Recs:
 
BUY: CELLDEX THERAPEUTICS INC NEW (CLDX) Rating: 4
Start Price: $3.95
Points: +13.36
Created: 09/20/2010
I've noticed some recent insider buying and the stock is at the lower end of it's 52 week range.

Comments: 0 | Comment

Recs:
 
BUY: CELLDEX THERAPEUTICS INC NEW (CLDX) Rating: 4
Start Price: $5.04
Points: -17.64
Created: 03/03/2010
Making moves on high volume. Recently broke free from the consolidation range.

Comments: 0 | Comment

Recs:
 
BUY: CELLDEX THERAPEUTICS INC NEW (CLDX) Rating: 4
Start Price: $4.67
Points: -9.87
Created: 01/01/2010
gain4grave

Comments: 0 | Comment

Recs:
 
BUY: CELLDEX THERAPEUTICS INC NEW (CLDX) Rating: 4
Start Price: $6.06
Points: -85.83
Created: 03/29/2009
Pick this as a quick hitter to pick up 10% after recent 11% pullback.

Comments: 0 | Comment

Recs:
 
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
mkittels 54.86 BUY Three to Six Months 01/28/2012 $4.49 $5.20
(+0.19%)
+15.81% +2.69% +13.13 view
buckeye33492 0.99 BUY Three to Six Months 09/20/2010 $3.95 $5.20
(+0.19%)
+31.65% +18.29% +13.36 view
OnIslandTrader 0.28 BUY One to Three Months 03/03/2010 $5.04 $5.20
(+0.19%)
+3.17% +20.82% -17.64 view
HappySmile 0.52 BUY Three to Six Months 01/01/2010 $4.67 $5.20
(+0.19%)
+11.35% +21.22% -9.87 view
Ragjack 2.26 BUY Week or Less 03/29/2009 $6.06 $5.20
(+0.19%)
-14.19% +71.64% -85.83 view
Sponsored Links